Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 6, 2009, Pages 1079-1083

  Yamada, Yoshiaki ^a   Itoh, Youko ^a   Aoki, Shigeyuki ^a   Nakamura, Kogenta ^a   Taki, Tomohiro ^a   Naruse, Katsuya ^a   Tobiume, Motoi ^a   Zennami, Kenji ^a   Katsuda, Remi ^a   Kato, Yoshiharu ^a   Watanabe, Masahito ^a   Nishikawa, Genya ^a   Minami, Miwako ^b   Nakahira, Mariko ^b   Ukai, Sayaka ^b   Sawada, Masaki ^b   Kitamura, Akiko ^b   Honda, Nobuaki ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Heat shock protein (HSP); M VAC chemotherapy; Mild hyperthermia; Transitional cell carcinoma; Urothelial cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER REGRESSION; CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTHERMIC THERAPY; MALE; METASTASIS; MOUTH TEMPERATURE; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; REMISSION; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UROTHELIUM; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; HUMANS; HYPERTHERMIA, INDUCED; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM METASTASIS; REMISSION INDUCTION; TREATMENT OUTCOME; UROLOGIC NEOPLASMS; VINBLASTINE;

EID: 69049104111     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-0964-2     Document Type: Article

References (24)

1. H Waehre S Ous B Klevmark, et al. 1993 A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer Cancer 72 3044 3051
2. MA Ghoneim MM el-Mekresh MA el-Baz, et al. 1997 Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1, 026 cases J Urol 158 393 399
3. P Bassi GD Ferrante N Piazza, et al. 1999 Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort J Urol 161 1494 1497
4. TG Schuster DC Smith JE Montie 2001 Pelvic recurrences post cystectomy: current treatment strategies Semin Urol Oncol 19 45 50
5. CN Sternberg A Yagoda HI Scher, et al. 1985 Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium J Urol 133 403 407
6. CN Sternberg A Yagoda HI Scher, et al. 1989 Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse Cancer 64 2448 2458
7. PJ Loehrer Sr LH Einhorn PJ Elson, et al. 1992 A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 10 1066 1073
8. SB Saxman KJ Propert LH Einhorn, et al. 1997 Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 15 2564 2569
9. H von der Maase SW Hansen JT Roberts, et al. 2000 Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 3068 3077
10. H von der Maase L Sengelov JT Roberts, et al. 2005 Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 4602 4608
11. L Dogliotti G Carteni S Siena, et al. 2007 Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial Eur Urol 52 134 141
12. K Miyata T Hasegawa K Maeda, et al. 2005 The activation of immunological activity and ant-tumor effects by mild hyperthermia Jpn J Hyperthermic Oncol 21 33 34
13. H Terunuma A Wada X Deng, et al. 2007 Mild hyperthermia modulates the relative frequency of lymphocyte cell subpopulations: an increase in a cytolytic NK cell subset and a decrease in a regulatory T cell subset Thermal Med 23 41 47
14. K Ahmed T Hori DY Yu, et al. 2008 Hyperthermia chemo-sensitization, chemical thermo-sensitization and apoptosis Thermal Med 24 1 12
15. YH Itoh R Noguchi 2000 Pre-treatment with mild whole-body heating prevents gastric ulcer induced by restraint and water-immersion stress in rats Int J Hyperthermia 16 183 191
16. Y Itoh K Ogawa K Tazawa, et al. 2008 Improvement of athletic performances by heat shock protein 70 induced with mild hyperthermia Jpn J Clin Physiol 38 13 21
17. M Yatsuzuka S Wada Y Hara, et al. 2005 Psychological characteristics after far-infrared hyperthermia evaluated using the profile of mood state (POMS) Jpn J Hyperthermic Oncol 21 231 235
18. CC Jaffe 2006 Measures of response: RECIST, WHO and new alternatives J Clin Oncol 24 1773 1782
19. National Cancer Institute Common Toxicity Criteria Version 3.0 (2006)
20. Y Yamada K Naruse K Nakamura, et al. 2007 Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization Oncol Rep 18 1183 1187
21. M Matsubara Y Yamada K Naruse, et al. 2008 Potential for HER-2/nen molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization Oncol Rep 19 57 63
22. F Ciardiello R Caputo R Bianco, et al. 2000 Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor Clin Cancer Res 6 2053 2063
23. Y Itoh K Tazawa K Wada, et al. 2005 Induction pf Hsp 70 in lymphovytes by whole body far-infrared hyperthermia Jpn J Hyperthermic Oncol 21 209 220
24. H Ono S Ando T Suzuki, et al. 2006 The drug uptake in the tumor when the mild-hyperthermia treatment in combination with the chemotherapy in vivo Jpn J Hyperthermic Oncol 22 23 32